.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Cerilliant
UBS
Baxter
Covington
Johnson and Johnson
Citi
Dow
AstraZeneca
Chubb

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
Abstract:The invention relates to combinations of angiotensin-converting enzyme inhibitors with calcium antagonists, processes for their preparation and their use as medicaments.
Inventor(s): Becker; Reinhard (Wiesbaden, DE), Henning: Rainer (Hattersheim am Main, DE), Ruger; Wolfgang (Kelkheim, DE), Teetz; Volker (Hofheim am Taunus, DE), Urbach; Hansjorg (Kronberg/Taunus, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Filing Date:Apr 11, 1994
Application Number:08/225,762
Claims:1. A pharmaceutical composition, comprising a) 1-[N-(1-S-1-[N-(1-S-ethoxycarbonyl-3-phenylpropyl)-S-alanyl]-(2S,3aR,7aS)- octahydro[1H]indole-2-S-carboxylic acid (trandolapril) or a physiologically acceptable salt thereof in combination with b) 4-(2,3-dichlorophenyl)-2,6-dimethyl-3-methoxycarbonyl-5-ethoxycarbonyl-1,4 -dihydropyridine (felodine) or a physiologically acceptable salt thereof, wherein a) and b) are present in a combined amount more effective to lower blood pressure than the individual amounts of either a) or b) administered separately.

2. A method for the treatment of high blood pressure, which comprises administering to a host in recognized need thereof an effective amount of a pharmaceutical composition as claimed in claim 1.

3. A method for the treatment of cardiac insufficiency, which comprises administering to a host in recognized need thereof an effective amount of a pharmaceutical composition as claimed in claim 1.

4. A method for the treatment of coronary heart disease, which comprises administering to a host in recognized need thereof an effective amount of a pharmaceutical composition as claimed in claim 1.

5. A pharmaceutical composition as claimed in claim 1, wherein said composition comprises a physiologically acceptable carrier.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKesson
Colorcon
Harvard Business School
Covington
Cerilliant
McKinsey
Chinese Patent Office
Baxter
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot